Paediatric drugs and the Traffic Light System


This guidance applies

  • only where a drug does not already have a TLS classification
  • only for paediatric patients within BNSSG
  • only for long-term use of a medicine where the patient would not otherwise visit the initiating clinician or unit at intervals of 60 days or less

 

Paediatric drugs are frequently used outside the makers Statement of Product Characteristics since many manufacturers fail to conduct the relevant trials need to secure licensed use in paediatrics.

 

Local guidance has made clear that the BNF for Children is the accepted reference.

 

 

Indication 

Drug 

In BNF-C for indication and dose range

In BNF-C but outside indications or dose range

Not in BNF-C

Licensed drug within SPC indications

Amber

No Shared Care Protocol (SCP) needed

Red

Off label use of drug

(as per BNF-C definition page 2)

Amber

if SCP agreed

Red

Unlicensed drug

Amber

if SCP agreed

Red

 

For details of how to obtain copies of the BNF for Children please contact your PCT / Trust principal pharmacist

Last updated by: Emily Knight on 03-11-2017 14:11